Caffeine is a frequently used and accepted pharmacologically active substance. 1 Exposure to caffeine is mainly through coffee and tea consumption. 2 Caffeine intake acutely increases blood pressure levels. Habitual caffeine consumption may be associated with chronic blood pressure levels or the risk of hypertension in nonpregnant adults, but results seem inconsistent. Even protective effects of caffeine intake and blood pressure levels have been found previously. [3] [4] [5] The mechanisms by which caffeine exposure affect heart rate and blood pressure levels might include increases of catecholamine levels, which might subsequently lead to vasoconstriction. 6, 7 Previous studies showed that higher levels of caffeine intake during pregnancy are associated with fetal growth retardation and fetal death, which might both be the result of early vascular placental adaptations. 8-10 However, it is not known whether caffeine intake also affects blood pressure during pregnancy. Differences in blood pressure levels associated with caffeine intake during pregnancy might be markers of subclinical cardiovascular adaptation mechanisms and the subsequent risk of hypertensive complications. Increased blood pressure during pregnancy might lead to hypertensive disorders, such as pregnancy-induced hypertension and pre-eclampsia, which are leading causes of maternal morbidity during pregnancy and neonatal complications. 11, 12 Pre-eclampsia occurs in ~5% of all pregnant women. Another 6% of pregnancies is complicated by pregnancy-induced hypertension. 13 Therefore, we examined the associations of habitual caffeine intake in different periods of pregnancy with repeatedly measured blood pressure levels and the risks of pregnancy-induced hypertension and pre-eclampsia in a population-based prospective cohort study among 7,890 pregnant women.
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onwards. The cohort includes 9,778 women and their children in Rotterdam, the Netherlands. Details have been described elsewhere. 14, 15 All pregnant women were enrolled between 2001 and 2005, and all children were born between April 2002 and January 2006. Of all eligible children in the study area, 61% participated at birth. 15 The Medical Ethical Committee of the Erasmus Medical Center in Rotterdam approved the study (MEC 198.782/2001/31) . Written consent was obtained from all participating parents. Enrolment was aimed in early pregnancy (gestational age <18.0 weeks) at the routine fetal ultrasound examination but was allowed until birth of the child. In total, 6,691 women were enrolled before a gestational age of 18 weeks. Assessments in pregnancy were planned in first, second, and third trimester. The individual timing of the assessment depended on the gestational age at enrolment. 14, 15 Population for analysis. In total, 8,880 women were enrolled during pregnancy. For this analysis, we excluded women without information on caffeine intake in any period of pregnancy (n = 781), and women without blood pressure measurements during pregnancy (n = 12) leading to 8,087 women. We subsequently excluded twin-pregnancies (n = 88), induced abortions (n = 16), fetal deaths (n = 55), women who were loss-tofollow-up (n = 32), and deliveries after <25 weeks of gestation (n = 6). Similar results were found after including fetal death in the analysis (Supplementary Tables S3 and S4 online). Thus, the cohort for analysis comprised 7,890 women (89% of 8,880) ( Figure 1) . Of all pregnancies, 5.9% were second (n = 461) or third (n = 8) pregnancies in the study. Since there were no differences in results after exclusion of these women, they were included in the analyses.
Caffeine intake. Information about maternal caffeine intake was obtained by postal questionnaires in each trimester of pregnancy. Response rates for these questionnaires were 91, 80, and 77%, respectively. 15 Women who reported any coffee or tea drinking were asked to categorize their average number of cups of coffee or tea per day, and what type of coffee or tea they consumed (caffeinated, caffeinated and decaffeinated, or decaffeinated). According to standard values for caffeine content, a regular coffee serving (125 ml) in the Netherlands contains about 90 mg of caffeine, decaffeinated coffee contains about 3 mg, and tea contains about 45 mg. 16 To calculate total caffeine intake in each trimester, we weighted the type of coffee or tea (caffeinated coffee = 1; caffeinated and decaffeinated coffee = 0.5; decaffeinated coffee = 0; caffeinated tea = 0.5; caffeinated and decaffeinated tea = 0.25; decaffeinated tea = 0; herbal tea = 0; green tea = 0.5). Thus, in our analyses each unit of caffeine intake reflects caffeine exposure based on one cup of caffeinated coffee (90 mg caffeine). Daily total caffeine intake was subsequently categorized (<2 units; 2-3.9 units; 4-5.9 units; 6 or more units). Total caffeine intake in first (n = 6,062), second (n = 6,329), and third (n = 5,972) trimester was correlated (Spearman's correlation coefficients ranged from 0.60 to 0.69 (P value <0.01)). We used the mean caffeine intake during pregnancy to assess the associations with longitudinally measured blood pressure levels and the risks of hypertensive pregnancy complications.
Blood pressure. Blood pressure was measured at our two dedicated research centers in each trimester of pregnancy, with the Omron 907 automated digital oscillometric sphygmanometer (OMRON Healthcare Europe, Hoofddorp, the Netherlands), which was validated in nonpregnant adults. 17 All participants were seated in upright position with back support, and were asked to relax for 5 min. A cuff was placed around the nondominant upper arm, which was supported at the level of the heart, with the bladder midline over the brachial artery pulsation. In case of an upper arm, exceeding 33 cm a larger cuff (32-42 cm) was used. The mean value of two blood pressure readings over a 60-s interval was documented. In total, blood pressure was measured in 6,071 women in first trimester (mean 13.5 weeks of gestation, range 4.5-17.9), in 7,451 women in second trimester (mean 20.6 weeks of gestation, range 18.1-24.9), and 7,547 women in third trimester (mean 30.4 weeks of gestation, range 25.1-39.2). In total, 21,069 blood pressure measurements were collected. Three, two, and one blood pressure measurements were available for 5,653, 1,873, and 364 women, respectively.
Hypertensive pregnancy complications. Information on pregnancy complications was obtained from medical records. Women suspected of pregnancy complications based on these records were crosschecked with the original hospital charts. 18 The following criteria were used to identify women with pregnancy-induced hypertension: development of systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg after 20 weeks of gestation in previously normotensive women. These criteria plus the presence of proteinuria 20 which gives a global severity index; a higher index reflects more stress.
Statistical methods. First, the associations of caffeine intake during pregnancy with repeatedly measured systolic and diastolic blood pressure were analyzed using unbalanced repeated measurement regression analyses. These models take into account the correlation between repeated measurements of the same subject, and allow for incomplete outcome data. 21 The best fitting models were constructed using fractional polynomials of gestational age. 22 Mean maternal daily caffeine intake during pregnancy (<2 units; 2-3.9 units; 4-5.9 units; 6 or more units) was included in these models as intercept and as interaction term with gestational age. The models can be written as:
Systolic blood pressure = β 0 + β 1 × caffeine + β 2 × gestational age + β 3 × gestational age −2 + β 4 × caffeine × gestational age Diastolic blood pressure = β 0 + β 1 × caffeine + β 2 × gestational age + β 3 × gestational age 0.5 + β 4 × caffeine × gestational age
In these models, "β 0 + β 1 × caffeine" reflects the intercept and "β 2 × gestational age + β 3 × gestational age −2 " reflects the slope of change in blood pressure per week for systolic blood pressure, and "β 2 × gestational age + β 3 × gestational age 0.5 " reflects the slope of change in blood pressure per week for diastolic blood pressure. Main interest was in the term "β 4 × caffeine × gestational age, " which reflects the difference in change in blood pressure per week between the different caffeine intake categories for either systolic or diastolic blood pressure. Second, the cross-sectional associations of maternal caffeine intake with blood pressure in first, second, and third trimester were assessed using multiple linear regression models. Linear regression models in which the caffeine intake categories were included as a continuous variable were considered as test for trend. Third, the associations of maternal caffeine intake with hypertensive pregnancy complications were assessed using multiple logistic regression models. All models were adjusted for gestational age at visit (only in cross-sectional analyses), body mass index, height, maternal age, ethnicity, educational level, parity, alcohol consumption, smoking habits, folic acid supplement use, total daily energy intake, and maternal stress. We imputed missing data of the covariates with the mean value for continuous variables, and added a separate category for missing values for categorical variables. The percentages of missing values within the population for analysis were lower than 10%, except for folic acid supplement use (22%), total daily energy intake (24%), and maternal stress (19%). These higher percentages were due the large number of mothers who were not enrolled in first trimester and therefore did not receive this specific questionnaire. No differences in results were observed between analyses with imputed missing data or complete cases only. The repeated measurement analysis was performed using the Statistical Analysis System version 9.2 (SAS, Cary, NC), including the Proc Mixed module for unbalanced repeated measurements. All other analyses were performed using the Statistical Package of Social Sciences version 17.0 for Windows (SPSS, Chicago, IL).
RESULTS
Maternal characteristics according to their caffeine intake are shown in Table 1 . Women with the highest daily caffeine intake (6 or more units) were older and had the highest weight at enrolment. Also, these women were more often of European ethnicity, tended to continue consumption of alcohol and smoking during pregnancy more frequently, had highest percentage of no folic acid supplement use, and the highest stress index score. Women with daily caffeine intake between 4 and 5.9 units were highest educated, taller, and used folic acid supplements preconceptional most often. Mean systolic blood pressure levels in third trimester differed significantly among the caffeine intake categories. Mean diastolic blood pressure levels were similar among all caffeine intake categories. In total, there were 237 cases (3.0%) of pregnancy-induced hypertension and 119 cases (1.5 %) of pre-eclampsia. Figure 2a ,b shows the results from our repeated measurement analyses of caffeine intake and systolic and diastolic blood pressure patterns, respectively. As compared to women using <2 units/day, we observed no differences in systolic and diastolic blood pressure levels for both the time-independent (intercept) and time-dependent (change in blood pressure with advancing gestational age) estimates for women who had more caffeine consumptions per day.
In the cross-sectional analyses, higher caffeine intake tended to be associated with elevated systolic blood pressure levels in first and third trimester (P for trend <0.05), but not in second 
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Caffeine and Blood Pressure in Pregnancy trimester. We found an increase in systolic blood pressure among the women who consumed between 4 and 5.9 units/day (1.17 mm Hg (95% confidence interval: 0.62, 2.81)) in third trimester, compared to women consumed <2 units of caffeine per day. Furthermore, no associations or trends were found in the cross-sectional analyses focused on the associations of caffeine intake with diastolic blood pressure ( Table 2) . Table 3 shows that we observed no associations of higher caffeine levels with the risk of pregnancy-induced hypertension. As compared to women with caffeine intake of <2 units/ day, those daily consuming 2-3.9 units of caffeine had a lower risk of pre-eclampsia (odds ratio of 0.63 (95% confidence interval: 0.40, 0.96)), but no associations were observed for higher caffeine levels.
We observed similar results after repeating the analyses with categories of no caffeine intake as reference group, instead of <2 units of caffeine per day (Supplementary Tables S1 and S2 online).
DISCUSSION
Findings from this study suggest that higher caffeine intake during pregnancy is associated with higher systolic blood pressure levels in first and third trimester. Caffeine intake does not seem to be significantly associated with diastolic blood pressure levels. As compared to women with caffeine intake of <2 units/day, those with higher caffeine intake had no increased risks of pregnancy-induced hypertension or pre-eclampsia.
Methodological considerations
One of the strengths of this study was the prospective data collection, which started in early pregnancy. In addition, we had a large sample size of 7,890 participants with 21,069 blood pressure measurements. The response rate of the study was 61%. Pregnant women who participated were higher educated, more healthy and more frequently of European origin than those who did not participate. 15 This might have led to some selection. However, selection bias in prospective follow-up studies primary arises from loss to follow-up instead of nonresponse at baseline. 23 Among mothers with information about coffee and tea consumption, we had a limited loss-to-follow-up. However, 
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Another potential limitation of our study might be the missing data on coffee and tea consumption. The associations may be underestimated if among mothers without caffeine data the percentage of consumers was higher than among mothers without missing data. However, this seems unlikely because no other differences in characteristics between mothers with and without information about coffee and tea consumption were observed. Information on coffee and tea consumption during pregnancy was collected by postal questionnaires. If any, misclassification would most likely be due to underreporting and subsequently lead to underestimation of differences between dosages of caffeine intake. 24 The questionnaires used to measure coffee and tea consumption was not validated in our study, which is another possible limitation of our study. However, many previous studies have used similar questions to assess coffee and tea consumption in their participants. In addition, self-reported coffee and tea consumption can be validated by comparison with biological samples or a 24-h recall method. James et al. 25 reported reliability of self-reported caffeine consumption by analyzing biological samples of their subjects on caffeine metabolites. Finally, we had information about a wide range of potential confounding factors available, but because of the observational design, residual confounding due to sociodemographic and lifestyle factors might still be an issue. Women with high-caffeine intake also were more often smokers and had higher alcohol consumption; therefore, differences in lifestyle habits between the caffeine groups can be expected.
Caffeine intake during pregnancy
We have very detailed information about caffeine consumption for coffee and tea. However, caffeine intake from other sources may also be relevant. It has previously been estimated that in adults, coffee and tea consumption comprises 96%. 26, 27 Other sources of caffeine (4%) can be found in cacao, chocolate, soft drinks, and caffeine-containing medication. Women without tea or coffee consumption, but using Values are regression coefficients with 95% confidence interval and reflect the difference in blood pressure in mm Hg compared to women who consumed <2 units of caffeine per day during that particular trimester. a Models are adjusted for gestational age at visit, body mass index at enrolment, height, maternal age at enrolment, ethnicity, educational level, parity, alcohol consumption, smoking habits, folic acid supplement use, total daily energy intake, and stress in pregnancy. b Tests for trends are based on multiple linear regression models with caffeine intake as a continuous variable. *P value <0.01. Values are odds ratios with 95% confidence interval and reflect the difference in risk of pregnancy complications compared to women who consumed <2 units of caffeine per day. a Models are adjusted for body mass index at enrolment, height, maternal age at enrolment, ethnicity, educational level, parity, alcohol consumption, smoking habits, folic acid supplement use, total daily energy intake, and stress in pregnancy. b Tests for trends are based on multiple logistic regression models with caffeine intake as a continuous variable. *P value <0.05.
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Caffeine and Blood Pressure in Pregnancy large amounts of caffeine intake might be underestimated for the exposure. Although consumption of caffeinated soft drinks is increasing, 1, 23 analyzing only coffee and tea consumption in this study seems sufficient in assessing the effect of caffeine on blood pressure levels during pregnancy. We categorized caffeine intake in units instead of calculating the exact milligrams of caffeine per day. Current practice is to advise pregnant women to not consume >300 mg caffeine. This guideline is based on studies focused on the effects of caffeine consumption on fetal outcomes. 9 ,28 Accordingly, we should acknowledge the possibility that low intake of caffeine may be a marker of health conscious lifestyle of the participating women. Previous studies showed that higher levels of caffeine intake during pregnancy are associated with fetal growth retardation and fetal death, which might both be the result of early adverse vascular placental adaptations. [8] [9] [10] The highest category of caffeine intake in our study (6 or more units) should be considered similar as caffeine intake of >540 mg/day. The amount of caffeine per coffee serving was estimated on 90 mg. 16 However, calculations of caffeine intake should be interpreted carefully and might be country specific. European coffee is typically stronger than coffee in the United States. 1 A standard coffee serving in the United States contains about 70 mg of caffeine.
Caffeine intake, blood pressure, and hypertensive complications
Previous studies have examined the associations between caffeine intake and blood pressure levels and the risk of hypertension. 4, [29] [30] [31] Thus far, results seem inconsistent. To our knowledge, the effect of caffeine intake during pregnancy on blood pressure levels has not been studied before in a population-based sample. Examining blood pressure levels in different trimester enabled us to identify specific critical periods during pregnancy for caffeine exposure. We found positive associations between caffeine intake and systolic blood pressure levels in first and third trimester of pregnancy. We did not find significant trends in our longitudinal analysis. Also, caffeine intake was not associated with diastolic blood pressure levels. No associations between higher caffeine intake and increased risks of pregnancy-induced hypertension or preeclampsia were observed. Ruder et al. suggested that women should limit their caffeine intake to promote fertility and to limit oxidative stress, which might lead to pregnancy complications such as pre-eclampsia. 32 However, to our knowledge no other studies observed associations of caffeine intake with hypertensive pregnancy complications. We observed a decreased risk of pre-eclampsia among women who consumed 2-3.9 units of caffeine per day. However, this finding was not consistent with the other categories or with previous studies. We cannot explain this lower risk. Residual confounding, due to insufficient or unmeasured lifestyle habits, might be involved. Further studies are needed in larger sample sizes. The mechanisms underlying the associations between caffeine intake and blood pressure during pregnancy are not known. During pregnancy vasodilatation and uteroplacental circulation lead to decreased total peripheral vascular resistance from early pregnancy onwards, with a mid-pregnancy fall in diastolic blood pressure. 33, 34 Mechanisms leading to this vasodilatation are not yet completely understood, but previous findings suggest a decreased vascular responsiveness to the pressor effects of angiotensin II and norepinephrine, 35 increased endothelial prostacyclin, 36 enhanced nitric oxide production, 37 and reduced aortic stiffness. 38 On the contrary, caffeine increases vasoconstriction, due to increased catecholamine levels. 6, 7 This might partly explain the associations in first and third trimester. Furthermore, Apostolakis et al. emphasized the importance and difficulties of identifying biomarkers for hypertensive disorders developed during pregnancy. However, they concluded that even though a biomarker whose effect in disease probability is not as strong, it may still give important information on the underlying disease pathophysiology, or help to identify new therapeutic targets. 39 Further studies are needed focused on these underlying mechanisms. In our study, we only used information about maternal blood pressure as measure of cardiovascular adaptation during pregnancy. Studies with information about more maternal or placental cardiovascular measures, such as arterial stiffness, cardiac function, and placental blood flow might give important additional information. Also, for this study we focused on caffeine intake during pregnancy based on coffee and tea consumption. However, we assess whether the association are only explained by caffeine intake. Coffee and tea contain other chemical substances, which may influence blood pressure levels. Research into the metabolites involved in pathways leading from coffee and tea intake to pregnancy complications is needed.
In conclusion, our results suggest that caffeine intake during pregnancy seems to be associated with higher systolic blood pressure levels in first and third trimester, but not with diastolic blood pressure levels. We did not find evidence of significant adverse associations of caffeine intake on maternal cardiovascular adaptations during pregnancy. The unexpected finding of a possible protective association with moderate caffeine intake deserves further investigation.
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